Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Autoimmune Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Testing effectiveness (Phase 2)Study completedNCT01929980
What this trial is testing

Bortezomib to Treat Significant Complication of HSCT

Who this might be right for
Allogeneic Stem Cell TransplantationRefractory Autoimmune Cytopenia(s)
Children's Hospital Medical Center, Cincinnati 4
Not applicableLooking for participantsNCT07143617
What this trial is testing

Exploratory Clinical Study on the Safety of STR-P004

Who this might be right for
Autoimmune Diseases
Beijing GoBroad Hospital 39
Not applicableEnded earlyNCT02050581
What this trial is testing

A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

Who this might be right for
Idiopathic Thrombocytopenia Purpura
Weill Medical College of Cornell University 72
Early research (Phase 1)Looking for participantsNCT07432334
What this trial is testing

CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Vinmec Research Institute of Stem Cell and Gene Technology 8
Not applicableLooking for participantsNCT07491016
What this trial is testing

Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis

Who this might be right for
TelitaciceptTreatment ComplianceRheumatoid Arthritis
Zhejiang Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06428188
What this trial is testing

Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Lupus Erythematosus Acute+1 more
Essen Biotech 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT00076752
What this trial is testing

Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Cancer Institute (NCI) 9
Very early researchUnknownNCT05239702
What this trial is testing

Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisDermatomyositis+2 more
Zhejiang University 75
Not applicableLooking for participantsNCT07126431
What this trial is testing

Prospective Cohort Study on Refractory Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Peking University Third Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06189157
What this trial is testing

MB-CART19.1 in Refractory SLE

Who this might be right for
SLE - Systemic Lupus Erythematosus
Miltenyi Biomedicine GmbH 29
Not applicableLooking for participantsNCT07052565
What this trial is testing

CAR-T Cells Therapy for Patients With Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Anhui Provincial Hospital 18
Post-approval studies (Phase 4)Study completedNCT07428551
What this trial is testing

Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular Juvenile Idiopathic Arthritis Patients

Who this might be right for
Juvenile Idiopathic ArthritisPolyarticular Juvenile Idiopathic ArthritisRefractory Polyarticular Juvenile Idiopathic Arthritis
Bangladesh Medical University 50
Not applicableActive Not RecruitingNCT07151157
What this trial is testing

Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease

Who this might be right for
Adult-Onset Still's Disease
Ruijin Hospital 3
Early research (Phase 1)Study completedNCT03676569
What this trial is testing

Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy

Who this might be right for
Refractory Epilepsy
Mossakowski Medical Research Centre Polish Academy of Sciences 6
Early research (Phase 1)Looking for participantsNCT06691152
What this trial is testing

Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine 18
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Not applicableLooking for participantsNCT07403188
What this trial is testing

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Who this might be right for
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4 more
Kyverna Therapeutics 70
Large-scale testing (Phase 3)WithdrawnNCT05063513
What this trial is testing

Autologous Stem Cell Transplantation: International Lupus Trial

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
European Society for Blood and Marrow Transplantation
Next Page